CG DIMONO PTX 1x1ML / 1x2ML
An innovative clinic-grade preparation developed by the renowned company Caregen, representing the world's first BTX type C peptide. The product has been designed as a modern and safe alternative to traditional therapies utilizing BTX type A. The formula combines the balanced properties of an advanced peptide complex and hyaluronic acid, which exhibit the ability to precisely act upon the deep structures of the epidermis and dermis in areas where architectural defects occur. The unique composition allows for simultaneously achieving effects characteristic of botulinum toxin, classic tissue fillers, and skinboosters. The preparation intensively strengthens the skin's framework, smooths depressions, and actively stimulates natural repair processes, restoring a refreshed and younger appearance to the tissues.
Action:
-
serves as an innovative alternative to traditional BTX type A therapies
-
effectively reduces the appearance of wrinkles, furrows, and nasolabial folds
-
combines the effects of BTX, tissue fillers, and skin boosters in a single treatment
-
smooths skin depressions and diminishes the visibility of expression lines
-
strengthens the skin structure and intensively stimulates its natural regeneration
Active ingredients:
-
Sodium Hyaluronate (1.0%) – a key moisture-binding component that fills the intercellular spaces in areas of depressions, ensuring proper tension, wrinkle smoothing, and adequate hydration
-
Peptide complex (Sh-pentapeptide-12 SP, octapeptide-11) – modern biomimetic molecules acting as an alternative to BTX type A; they work within the deep layers of the skin, reducing muscle tension, smoothing folds, and initiating tissue renewal processes
INCI ingredients:
PBS (Phosphate Buffered Saline), Sodium Hyaluronate, Sh-Pentapeptide-12 SP, Octapeptide-11.
Directions for use:
Before starting the procedure, an anesthetic cream must be applied to the cleansed treatment area. The preparation is administered via intradermal injection. The recommended dosage for specific anatomical zones is as follows: forehead (1–2 ml), nasolabial folds (0.5–2 ml), eye area (0.5–1 ml), mouth area (0.5–1 ml), and lips, neck, or cleavage (0.5–2 ml). Immediately following the injection, a cold mask should be applied to the treated area for 10 to 20 minutes. The recommended frequency of the therapeutic program involves performing 1 treatment every 2–3 months, which corresponds to a series of 4–5 sessions per year.
Packaging:
The packaging is available in volume variants of: 1 syringe with a capacity of 1 ml or 1 syringe with a capacity of 2 ml.
Product may only be used by professionals. By deciding to purchase, you declare that you are a doctor or cosmetologist trained in the field of aesthetic medicine.